Aims: The aim of the study was to compare the influence of gap junctional communication (GJC) in osteoclastogenesis from bone marrow (BM) and peripheral blood (PB) monocytes. These widely used sources differ in purity, since BM cultures contain a significant number of stromal cells. We studied whether stimulation of GJC in BM monocyte/stromal cell cultures differs from the effect in pure PB monocyte cultures. We compared the differentiation also in acidosis, which is a known inducer of bone resorption. Main methods: Human BM and PB monocytes were isolated from BM aspirates or whole blood samples. The cells were cultured on human bone slices with osteoclastogenic growth factors and a GJC modulator, antiarrhythmic peptide AAP10, at physiological and acidic pH. Key findings: Both BM and PB monocytes differentiated into osteoclasts. Acidosis increased resorption in both cultures but stimulated cell fusion only in BM cultures, which demonstrates the role of stromal cells in osteoclastogenesis. At physiological pH, AAP10 increased the number of multinuclear cells and bone resorption in both BM and PB cultures indicating that GJC is involved in differentiation in both of these osteoclastogenesis assays. Interestingly, in PB cultures at pH 6.5 the stimulation of GJC with AAP10 inhibited both osteoclastogenesis and bone resorption suggesting a different role of GJC in BM and PB monocytes at stressed environment. Significance: The study is conducted with primary human tissue samples and adds new knowledge on factors affecting osteoclastogenesis from different monocyte sources.
Introduction
Osteoclasts are multinuclear bone-resorbing cells differentiated from the monocyte/ macrophage lineage [1, 2] . In addition to bone marrow (BM) peripheral blood (PB) has also been shown to contain cells capable of fusion into bone-resorbing polykaryons [3, 4, 5, 6] . Osteoclasts can be generated in vitro from BM or PB monocytes with receptor activator for nuclear factor kB ligand (RANKL) and macrophage colonystimulating factor (M-CSF) [7, 8] . The addition of transforming growth factor beta (TGF-b) and dexamethasone can enhance osteoclastogenesis and the activity of osteoclasts [9, 10] . However, contradictory effects of TGF-b on osteoclastogenesis have been reported [11] , and the outcome is also affected by the presence of stromal cells in the culture [12, 13] .
The main osteoclast precursors have been shown to be the monocyte subpopulation CD14 þ CD16 À cells [14, 15, 16, 17, 18] . The major monocyte type in PB is the classical (CD14 þþ CD16 À ) monocyte, whereas BM contains mostly intermediate [19, 20] . It has been shown that after initial differentiation in hematopoietic tissues, the cell cycle-arrested quiescent osteoclast precursors (QOPs) circulate in the bloodstream before homing to bone surfaces for final osteoclastogenesis [21, 22] . The minor monocyte subpopulations in PB, the nonclassical (CD14 þ CD16 þþ ) and intermediate monocytes, have also been shown to differentiate into osteoclasts [19, 23] . However, the osteoclasts differentiated from distinct monocyte subsets seem to be functionally different. Sprangers et al. suggest that the main source of osteoclasts under physiological conditions are the classical monocytes, whereas the intermediate monocytes differentiate into osteoclasts with an increased bone resorption ability under inflammatory conditions [23] .
Cell fusion in osteoclastogenesis is a multifactorial process involving various fusion proteins as well as gap junctional communication (GJC). Gap junctions are comprised of two connexon hemichannels, which allow the intercellular transfer of small molecules. Hemichannels can also act as unopposed channels without gap junction formation in mediating communication between the cell and the extracellular environment. The hemichannels/connexons consist of six connexin (Cx) subunits, of which Cx43 is the most abundant in bone tissue. Gap junctions are widely expressed in bone, and GJC has been shown to be important in the overall maintenance of bone homeostasis, as well as more specifically in osteoclastogenesis, bone resorption and osteoclast survival [24, 25, 26, 27] . Several studies have shown that blocking of GJC during osteoclastogenesis leads to a decreased number of osteoclasts [24, 25, 26, 28, 29] . In addition, Pacheco-Costa et al. [30] showed that osteoclasts in mice lacking Cx37 are smaller and have fewer nuclei, indicating that Cx37 is needed for the proper fusion of the cells. The precise mechanisms behind this are not known, but GJC has been suggested to be involved especially in the fusion of the mononuclear osteoclast precursors, since Cx43 mRNA expression was shown to be time-dependently downregulated in the course of differentiation [26] . In addition to the regulation of osteoclastogenesis directly by the osteoclast gap junctions, it is possible that GJC in other bone cells affects the differentiation. Zhang et al. [31] provided evidence that Cx43 ablation in osteocytes leads to an increased RANKL/osteoprotegerin (OPG) ratio supporting osteoclastogenesis, and
Watkins et al. [32] have shown that altered GJC in osteoblasts can have indirect effects on osteoclasts.
GJC can be enhanced with a group of synthetic antiarrhythmic peptides (AAP). Their proposed mechanism of action is increasing total Cx expression and promotion of PKCa-dependent phosphorylation of Cx43 [33, 34, 35, 36] . In bone tissue, rotigaptide, one of the improved and more stable AAPs, has been shown to increase GJC in human osteoblasts and to prevent ovariectomy-induced bone loss in rats [37] . We have previously shown that GJC is involved in osteoclastogenesis in mouse cell cultures, and that GJC in these cultures can be selectively affected with a group of novel AAPs [28] .
In regard to the clinical background of the study, several Cx mutations have been identified that lead to either minor symptoms or to severe diseases, such as oculodentodigital dysplasia [38] . In addition, inflammation and GJC are linked to each other [39] . Inflammation causes defective GJC, or on the contrary, certain pathogens can utilize GJC to spread the inflammation in the central nervous system [40] . This is an interesting point considering that the functions of bone cells and the immune system are tightly coupled [41] . Further, aging is well known to cause bone loss, and from this point of view Genetos et al. [42] have provided an interesting observation of age-related defects in GJC and in the formation of functional gap junctions in osteoblasts. Therefore, with the global aging of the population, it is important to study the relationships of these issues thoroughly. While antiarrhythmic peptides can rescue GJC in heart [43, 44, 45] , a similar approach in cellular coupling in bone could be valuable in skeletal disorders as well.
It is known that GJC influences bone remodeling and the coupling of bone cells but it is unclear whether the influence on osteoclasts is direct or indirect. Here we investigated osteoclasts generated from circulating or bone marrow derived human monocytes. The BM in vitro culture also contains stromal cells but the PB model is deficient of cells other than monocytes. Inflammation is usually associated with low pH [46] that stresses cells and inhibits GJC [47] . Thus we studied whether acidosis or pharmacological stimulation of GJC could have variable effects in pure circulating monocytes compared to cultures containing both monocytes and stromal cells.
Materials and methods

Osteoclastogenesis from human BM mononuclear cells
The isolation and culture methods were modified from Susa et al. [9] . BM samples were obtained from hip replacement surgery patients in Oulu University Hospital. The patients were 79e85 year-old men and women who all gave a written informed At the one-week time point, all the medium was refreshed (200 ml/well), but otherwise only half (100 ml) was refreshed every 3e4 days. Cells were cultured at þ37 C (5% CO 2 , 95% air) for 12 days and fixed with 4% PFA in PBS.
Osteoclastogenesis from human PB mononuclear cells
PB mononuclear cells were collected from whole blood samples after written informed consent from healthy or patient donors using Ficoll-Paque Premium gradient centrifugation as described earlier. The patients were 28e75 year-old men and women. Cell culture was done in a similar way to the BM sample, and the same number of cells were cultured on the human bone slices. Differentiation to osteoclasts was induced with 20 ng/ml RANKL (PeproTech EC) and 10 ng/ml M-CSF (R&D Systems). Acidification of the culture medium and medium changes were done as described earlier. Cells were cultured at þ37 C (5% CO 2 , 95% air) for 14 days and fixed with 4% PFA in PBS.
Gap junction modulation
Gap junctions were treated with 100 mM gap junction modulator peptide AAP10 (H 2 NGly-Ala-Gly-4Hyp-Pro-Tyr-CONH2; Zealand Pharma, Copenhagen, Denmark). The peptide was dissolved in water and added to the cultures once daily.
Analysis of cell fusion: counting of multinuclear cells
The actin cytoskeleton of the cells was stained with Alexa 488-conjugated phalloidin 
Statistical analysis
All cell culture experiments were done with groups of n ! 3 and repeated at least three times. Statistical analyses were performed using the SPSS statistics program version 22 (SPSS Inc., Chicago, IL). The normality of the response variables was tested by the Kolmogorov-Smirnov test and histogram visualization. This analysis revealed that the response variables were not normally distributed. Statistical differences between the test groups were evaluated using the Kruskal-Wallis test, and comparison between specific groups was done with the Mann-Whitney U-test.
The graphical presentation of the results was created with OriginPro 9.1 software (OriginLab, Northampton, MA). p < 0.05 was considered significant. The data are shown as means AE SEM.
Results
The effects of AAP10 on multinuclear cell number generated from human BM and PB monocytes
Osteoclastogenesis from BM and PB monocytes was analyzed both at physiological pH 7.4 and acidic pH 6.5 since AAPS have been assumed to be more active during acidosis or other metabolic stress [37, 48, 49] .
Multinuclear cells in both cell cultures were TRACP positive (Fig. 1a) . In addition, Culturing the BM cells in medium at acidic pH 6.5 instead of physiological pH 7.4 had a dramatic effect on the amount of multinuclear cells (Fig. 1b) . The acidic pH increased the number of multinuclear cells in the control group significantly (p < 0.001). In PB cultures the acidic pH decreased slightly but not significantly the number of multinuclear cells.
The effects of AAP10 on the number of multinuclear cells are shown in Fig. 1b . In both cell types AAP10 increased the number of multinuclear cells at physiological pH 7.4, and the effect was statistically significant (p < 0.001). In acidic conditions AAP10 had no effect on the BM cultures, but decreased the number of multinuclear cells in PB cultures (p < 0.01).
The effects of AAP10 on bone resorption of human BM and PB osteoclasts
Both BM and PB derived osteoclasts resorbed bone actively (Fig. 3a) . Acidosis increased the resorbed area in both cultures (p < 0.001 in BM and p < 0.01 in PB culture) (Fig. 3b) . Also AAP10 increased resorption pit area in cultures at pH 7.4 (p < 0.05 in BM and p < 0.001 in PB cultures). In BM cultures at pH 6.5, AAP10 did not have a significant effect on resorption pit area, but in PB cultures under acidic conditions, AAP10 decreased the resorbed area (p < 0.05).
The effects of AAP10 on GJC in osteoblast lineage MC3T3 cells
MC3T3 cells grown on glass slides appeared as a confluent cell layer having connections between the cells (Fig. 4a) . The figure shows the effect of photobleaching in 
Discussion
Regardless of the differing monocyte populations in BM and PB, they differentiate into multinuclear bone resorbing osteoclasts. Here we show for the first time that stimulation of GJC by the peptide AAP10 increases osteoclastogenesis at physiological pH in both human BM and PB monocyte cultures. This suggests that gap junctions are involved in human osteoclastogenesis, and that both the BM and PB monocytes utilize gap junctions in cell fusion, although GJC is not indispensable in the fusion process. It is well known that acidosis promotes osteoclast formation and survival [50, 51] and increases osteoclastic bone resorption [52, 53] . In our study acidification of the cell culture medium resulted in a threefold increase in osteoclastogenesis and a twofold increase in bone resorption in BM cultures. Acidification did not have an effect on osteoclastogenesis in PB cultures, but it increased bone resorption twofold. A possible explanation to this could be that the effects of acidosis are partly mediated by the stromal cells present in the bone marrow cultures. Osteoblast precursors have been shown to express proton receptors [54] , and based on this, Fuller and Chambers [55] remarked that the direct effects of acidosis on osteoclasts could be derived from the contaminating stromal cells in the BM cultures.
Acidosis is a typical stress which might close gap junctions [47] . This could explain our results in acidosis, where cell fusion was not affected with AAP10 in BM cultures. We suggest that acidosis causes the closure of gap junction channels, and AAP10 is not able to restore their open state. In this regard AAP10 is not as effective as another AAP, ZP123, also termed rotigaptide, which has been shown to attenuate gap junction closure during acidosis. There are also other studies supporting the idea that the AAPs are active only during metabolic stress [37, 49, 56, 57] . We believe that although the gap junction channels are closed during acidosis, the normal level of osteoclastogenesis observed in BM cultures occurs due to other fusion mechanisms, probably also with the help of stromal cells present in the BM cultures, which might secrete substances that promote osteoclastogenesis. This signaling between osteoblasts, osteoclasts and their precursors is well studied [58] , and it can lead to either increased or decreased osteoclastogenesis. Watkins et al. [32] have shown that GJC modulation in osteoblasts can regulate osteoclastogenesis indirectly by paracrine signaling. The schematic representation of the effects of AAP10 on osteoclastogenesis from human BM and PB monocytes is shown in Fig. 5 . The decreased osteoclastogenesis observed in PB cultures may result from the lack of stromal cells and their complementary effect on osteoclastogenesis.
FRAP analysis showed that AAP10 improves GJC in bone cells. The effect was shown with the osteoblast lineage MC3T3 cells which form a confluent, even layer of cells connected to each other, thus being suitable for the FRAP experiment and for the evaluation of the diffusion of the dye from cell to cell through gap junctions. We also tried FRAP with the BM and PB cultures, but due to the heterogeneous nature of these cultures, it was difficult to find the proper cells for bleaching. In addition, the osteoclast cultures in our study were conducted for 12 or 14 days and knowing the exact times of the cell fusions when GJC occurs during osteoclastogenesis turned out to be challenging. As mentioned earlier, GJC in osteoclastogenesis is not the main mechanism of fusion, therefore, finding the cells connected with gap junctions was difficult.
It is unclear whether the effects seen in our study are conducted between docked gap junctions or unopposed hemichannels. We also cannot exclude the possibility that the effects are caused solely by altered PKC-signaling, which has been proposed to be the main mechanism of action of AAPs. One explanation could be that only hemichannels are activated with AAP10, and this improves signaling between the cell and the extracellular environment, where also stromal cells contribute to the effects seen. The relatively high (100 mM) concentration needed to achieve our results has been noted also in other studies with gap junction modulators. Ponsaerts et al.
[59] also used a concentration of 100 mM for modulation of Cx43 hemichannels. Iyyathurai et al. [60] suggest that the high concentration is needed for the cellentry and even distribution of the peptide modulators inside the cell, and likely also reflect their low affinity in binding to their target regions. We performed also dose-response experiments with lower concentrations, but did not observe any effects with concentrations lower than 100 mM.
We have identified a possible problem in that the patients in our study do not match in age. The group donating the blood samples was younger on average compared to the group donating the bone marrow sample. Age might affect osteoclastogenesis, therefore, ideally, the study should have been made with age and sex matched groups. We would like to emphasize that the study is conducted with the valuable primary human samples from femur bone marrow requiring a highly invasive procedure, which limits the number of available samples.
BM and PB derived osteoclasts differ in morphology and the ability to resorb bone. [23] . In our study, the BM-derived osteoclasts were extremely robust in bone resorption compared to the PB-derived osteoclasts. We believe that our results support their hypothesis of classical monocytes from PB being the main source of osteoclasts, whereas intermediate monocytes from the BM would be activated in acidosis and to have an increased bone-resorbing capacity.
These BM and PB cultures differ in concentration of RANKL. RANKL has been shown to activate bone resorption in a concentration-dependent manner [61, 62, 63] . However, in studies conducted with mouse and rat cells, the resorption activity was saturated already at 10e20 ng/ml concentration and addition of 100 ng/ml [61] or even 500 ng/ml [63] RANKL did not further increase resorption. It has also been demonstrated that osteoclastogenesis and bone resorption are regulated by different factors [55] . Although it is well known that RANKL induces osteoclastogenesis and osteoclast survival, little is known about the effects of RANKL on mature osteoclasts. Fuller and Chambers demonstrated increased RANKL-induced resorption in mature mouse osteoclasts harvested from plastic substrate [55] , but since their protocol differs greatly from ours, direct conclusions from mouse experiments cannot be made concerning human osteoclasts. We have noticed that while RANKL is essential in osteoclastogenesis from human monocytes, its influence in increasing bone resorption is less clear. Based on these facts, we chose to use two different culture protocols optimized for the monocytes derived from BM and PB. The RANKL concentrations in our cultures (50 ng/ml in BM and 20 ng/ml in PB) are at a level sufficient for osteoclastogenesis, but on the contrary not too apart to cause dramatic differences on bone resorption. However, further experiments are needed to discover the effects of RANKL on resorbing osteoclasts and their activation.
It is possible that for the final differentiation into bone-resorbing osteoclasts the precursors require molecules secreted by the stromal cells, which are present in the BM environment. Since we used TGF-b and dexamethasone in addition to RANKL and M-CSF only in BM cultures, the differences between the osteoclast types might also indicate the pronounced effect of these additional growth factors on osteoclastogenesis. Several studies have shown that RANKL and M-CSF alone are sufficient to induce osteoclastogenesis from PB monocytes [17, 18, 64] , but other studies highlight the importance of TGF-b as a costimulating agent in osteoclastogenesis both from PB and BM monocytes [9, 10] . Susa et al. [9] presented the idea that RANKL and M-CSF induce mainly the differentiation of macrophage polykaryons rather than active osteoclasts, which could also be the explanation for our results.
Conclusion
This study shows that although the osteoclast cultures from human BM and PB have different features, GJC is presumably involved in osteoclastogenesis in both cultures.
Modulation of GJC with AAP10 increases osteoclastogenesis in both cultures at physiological pH, but differences in the effects appear at low pH. This indicates that the monocytes from BM and PB respond differently to environmental changes, which might be explained by the presence of the osteoclastogenesis supporting stromal cells in BM cultures.
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